Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) Reports Second Quarter Financial Results

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MALVERN, Pa., Aug. 6, 2013 /PRNewswire/ --

•Total quarterly revenues of $767 million, decreased by 2 percent versus prior year.

•Second quarter reported diluted (GAAP) EPS of $0.30; Second quarter adjusted diluted EPS of $1.42 increased by 12 percent versus prior year.

•Company now expects 2013 revenues in the range of $2.70 billion to $2.80 billion.

Hey, check out all the research scientist jobs. Post your resume today!
MORE ON THIS TOPIC